Clinical Trials · NCT02458716
Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Rutgers, The State University of New Jersey
- Enrollment
- 26
- Start date
- Mar 2015
- Locations
- 3 sites, United States
- Primary endpoint
- Rate of major peri-operative complications defined as Clavien-Dindo grade III or higher